scispace - formally typeset
L

Lee H. Harrison

Researcher at University of Pittsburgh

Publications -  434
Citations -  46417

Lee H. Harrison is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Population & Neisseria meningitidis. The author has an hindex of 97, co-authored 405 publications receiving 43026 citations. Previous affiliations of Lee H. Harrison include Centers for Disease Control and Prevention & Emory University.

Papers
More filters
Journal ArticleDOI

Group B Streptococcal Disease in the Era of Intrapartum Antibiotic Prophylaxis

TL;DR: In this paper, the authors analyzed trends in the incidence of group B streptococcal disease from 1993 to 1998 and estimated that 3900 early-onset infections and 200 neonatal deaths were prevented in 1998 by the use of intrapartum antibiotics.
Journal ArticleDOI

Should vascular surgery patients be screened preoperatively for methicillin-resistant Staphylococcus aureus?

TL;DR: A decision-analytic computer simulation model showed preoperative MRSA testing to be cost-effective (incremental cost-effectiveness ratio, <$50,000 per quality-adjusted life year) when the MRSA prevalence is ≥0.01 and the decolonization success rate is ≤0.25.
Journal ArticleDOI

Whole Genome Sequencing to Investigate the Emergence of Clonal Complex 23 Neisseria meningitidis Serogroup Y Disease in the United States

TL;DR: Investigation of genetic differences between isolates from early and late N. meningitidis populations found changes in antigen profile likely allowed the late population to emerge due to escape from population immunity, and may predict which antigenic factors are important in the cyclic epidemiology of meningococcal disease.
Journal Article

Identification of a high-risk heterosexual population for HIV prevention trials in Rio de Janeiro, Brazil.

TL;DR: This study demonstrates the usefulness of the newly described S/LS assay which allows one to estimate HIV incidence from single serum specimens and identifies a heterosexual population in Rio de Janeiro with a high rate of HIV transmission willing to participate in placebo-controlled vaccine trials.